Latest Liquidia News & Updates

See the latest news and media coverage for Liquidia. We track all announcements, press releases, and industry mentions in real time, all in one place.

Liquidia

Biopharmaceutical company developing inhaled therapies for cardiopulmonary diseases

liquidia.com

Headquarters: Morrisville, United States
Founded year: 2004
Company type: Public company
Number of employees: 50–350
Industry: Pharmaceuticals

Last updated Today

Latest news about Liquidia

In short: Liquidia settled with United Therapeutics for $380.7M, losing a key Yutrepia indication, while securing new funding.

Company announcements

Today Liquidia

Liquidia hires new executive director

The company is recruiting an Executive Director for Clinical Pharmacokinetics in North Carolina and encourages applications or sharing.

October 13 Liquidia

Liquidia settles litigation with United Therapeutics for $380.7 million

The agreement resolves all pending lawsuits, maintains YUTREPIA access, and includes payments to resolve antitrust claims.

October 11 Liquidia

Liquidia hires new Clinical Product Training Manager

Seeking a candidate for the Northeast US region to manage product training initiatives.

October 10 Liquidia

Liquidia hires a Financial Compliance and Operations Associate

The role is based in Morrisville, North Carolina. Candidates are encouraged to apply or share the posting with their professional network.

Media coverage

October 13 The Wall Street Journal

Under the Radar: Liquidia Stock Soars After Settling Patent Fight

Shares of Liquidia surged nearly 30% this morning after the company settled six lawsuits with rival United Therapeutics, ending multiyear litigation that had threatened to...

October 2 Seeking Alpha

Liquidia extends losses as Wells Fargo adds to downgrades on legal setback

Liquidia (LQDA) stock slips after a patent ruling tied to United Therapeutics' Tyvaso, sparking downgrades including the latest one from Wells Fargo. Read more here.

October 1 Law360

Liquidia's Yutrepia Found To Infringe Lung Treatment Patent - Law360

A Delaware federal judge has ruled that Liquidia was infringing two claims of a patent covering methods of treating pulmonary hypertension associated with interstitial lung...

September 30 MSN

Liquidia slumps after US court rules for United Therapeutics in patent fight

Sept 30 (Reuters) - Liquidia shares plunged nearly 50% on Wednesday after a federal judge ruled that its lung drug infringes key patent held by...

Never miss news about Liquidia

Track Liquidia and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Liquidia competitors & trending companies

Browse news for competitors to Liquidia and other trending companies.